Loading...
Market
First Targeted Inflammatory Disease for cNST-Based Treatments by 2025
5
Resolution / Starting Odds
Arthritis • 25%
Crohn's Disease • 25%
Multiple Sclerosis • 25%
Psoriasis • 25%
Medical journals and ColumbiaMed press releases
Story
Study: cNST in Brain Regulates Immune System, ColumbiaMed Research Shows
May 2, 2024, 09:47 AM
Recent research has uncovered a significant link between the brain and immune system regulation. Scientists, including HHMI Investigator Charles Zuker and colleagues from ColumbiaMed and ZuckermanBrain, have identified a specific brain region that communicates with the body's immune system through vagal neurons. This interaction, involving the cNST, can either enhance or suppress inflammation. The study, detailed in Nature, utilized advanced techniques such as single-cell sequencing, functional imaging, and spatial omics to map out a new neural circuit in the brain. This discovery not only advances our understanding of the body-brain axis but also highlights potential new avenues for treating inflammatory diseases.
View original story
Similar markets
Autoimmune diseases • 25%
Neurodegenerative diseases • 25%
Chronic pain management • 25%
Other inflammatory conditions • 25%
Pharmacological • 25%
Gene therapy • 25%
Neural modulation • 25%
Immunotherapy • 25%
Parkinson's Disease • 25%
Alzheimer's Disease • 25%
Multiple Sclerosis • 25%
Epilepsy • 25%
Nature • 25%
Science • 25%
The Lancet • 25%
Cell • 25%
Liver Disease • 25%
Cystic Fibrosis • 25%
Muscular Dystrophy • 25%
Hemophilia • 25%
Cardiovascular diseases • 25%
Neurodegenerative diseases • 25%
Cancer • 25%
Rare genetic disorders • 25%
Cancer • 25%
Alzheimer's Disease • 25%
Cystic Fibrosis • 25%
Sickle Cell Disease • 25%
Cancer • 25%
Rare Genetic Disorders • 25%
Heart Disease • 25%
Neurodegenerative Diseases • 25%